Target intelligence / Profile preview

EPHA1 antisense RNA 1 (EPHA1-AS1)

Target
EPHA1-AS1
Molecular classification
Long non-coding RNA, Other
01

Overview

EPHA1 antisense RNA 1 (EPHA1-AS1) is a long non-coding RNA (lncRNA) transcribed antisense to the EPHA1 gene region. It does not encode a protein but is thought to play a regulatory role in controlling the expression of the EPHA1 gene, which encodes a receptor tyrosine kinase involved in developmental processes, especially in the nervous system[1][7]. Polymorphisms within or near the EPHA1-AS1 locus have been linked to altered risk for neurodevelopmental and neurodegenerative diseases, such as intellectual disability and Alzheimer’s disease, likely by modulating either EPHA1 expression or affecting the activity of pathways like JAK2/STAT3 signaling[1][3][5]. Because it is a regulatory RNA and not a protein, EPHA1-AS1 is not itself a traditional drug target (such as a receptor or enzyme), but certain SNPs in its region may serve as genetic biomarkers for disease risk or prognosis[1][3][7].

Other names
EPHA1-AS1EPHA1 antisense RNA 1 (non-protein coding)LOC285965
02

Biological functions

Regulation of EPHA1 gene expression[1][3][5][7]Transcriptional regulation[1][3]May modulate downstream signaling such as JAK2/STAT3 pathway[3]
03

Disease associations

Cancer (implicated in gene region studies)[6]Neurodegenerative disease (Alzheimer’s disease association via regulatory SNPs and expression effects)[3][5]Intellectual disability (linked through variants affecting EPHA1-AS1/EPHA1)[1]
04

Biomarkers

Certain SNPs (e.g., rs11771145, rs11767557) as genetic susceptibility markers for intellectual disability and possibly neurodegenerative disease[1][3]

Beyond the preview

Go deeper on EPHA1 antisense RNA 1 (EPHA1-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on EPHA1 antisense RNA 1 (EPHA1-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call